ImmVirX is a clinical stage oncology company developing novel oncolytic viruses to create powerful cancer immunotherapy combinations.
ImmVirX
Developing a proprietary oncolytic immunotherapy targeting cancer indications with high unmet need.
Date Founded
2019
Founders / Management
Dr Malcolm McColl & Prof. Darren Shafren - Founders
HQ
Newcastle, NSW
Location(s)
Australia
Website
-
LinkedIn
-
Twitter
-
Facebook
-
Instagram
-
Contact
-